Poland· PL-100165318
Cubicin
A daptomycin product containing daptomycinum, registered in Poland by Merck Sharp & Dohme B.V.. The same ATC class is registered in 17 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Daptomycin is registered in 17 of 19 countries.
Countries holding a registration under ATC J01XX09 (daptomycin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Daptomycin · ATC J01XX09
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of daptomycin costs, country by country.
Normalised to the WHO defined daily dose (0.28 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Daptomycin · price per daily dose (0.28 g)
USD · FX 28 Sept 2026
- CH Switzerland$88.75
The record
At a glance
URPL (Poland)- Active substance
- Daptomycinum
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Poland (PL)
- ATC code
- J01XX09
- ATC class
- Daptomycin
- Defined daily dose
- 0.28 g, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990627271
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
25 interactions on record for daptomycin.
Graded by severity as the source publishes them — 18 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Daptomycin · interactions on record
25 records
- 18 moderate
- 2 minor
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- IbuprofenC01EB16moderate
- SimvastatinC10AA01moderate
- RosuvastatinC10AA07moderate
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Daptomycin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainCUBICIN 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSIONMerck Sharp & Dohme B.V.
- United KingdomCubicin 350mg powder for concentrate for solution for infusion vialsMerck Sharp & Dohme (UK) Ltd
- SwedenCubicin 350 mg Pulver till injektions-/infusionsvätska, lösningMerck Sharp & Dohme BV
- FinlandCubicinMerck Sharp & Dohme B.V.
- IrelandCubicin 350 mg powder for solution for injection or infusionMerck Sharp & Dohme BV
- CzechiaCUBICINMerck Sharp & Dohme B.V., Haarlem
- IcelandCubicinMerck Sharp & Dohme B.V.*
- BelgiumCubicin 350 mgMerck Sharp & Dohme
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Daptomycin Accord Healthcare, Daptomycin Accordpharma
- Belgium · Daptomycine Hikma
- Bulgaria · Даптомицин Mip
- Cyprus · Daptomycin Cooper 350mg, Daptomycin Cooper 500mg
- Czechia · Daptomycin Accordpharma
- Germany · Daptomycin Accord, Daptomycin Accord Healthcare
- Denmark · Daptomycin "hameln", Daptomycin Accord Healthcare
- Estonia · Daptomycin Norameda
- Spain · Daptomicin Tarbis, Daptomicina Accord
- Finland · Daptomycin Accord Healthcare, Daptomycin Accordpharma
- France · Daptomycin Fosun Pharma, Daptomycin Tillomed
- United Kingdom (Northern Ireland) · Daptomycin, Daptomycin Accord Healthcare
- Greece · Daptomycin Accord Healthcare, Daptomycin Accordpharma
- Croatia · Daptomicin Accord Healthcare, Daptomicin Accordpharma
- Hungary · Daptomycin Anfarm, Daptomycin Hameln
- Ireland · Daptomycin Accord Healthcare, Daptomycin Accordpharma
- Iceland · Cubicin, Daptomycin Hameln
- Italy · Daptomicina Accord, Daptomicina Accordpharma
- Liechtenstein · Cubicin, Daptomycin Hospira
- Luxembourg · Daptomycin Eberth, Daptomycine Hikma
- Malta · Daptomycin Anfarm, Daptomycin Dr. Reddys
- Netherlands · Daptomicin Accord Healthcare, Daptomicine Accord Healthcare
- Norway · Cubicin, Daptomycin Accord Healthcare
- Portugal · Daptomicina Accord Healthcare, Daptomicina Accordpharma
- Romania · Daptomicină Dr. Reddy’s, Daptomicină Mip
- Sweden · Daptomycin Accord Healthcare, Daptomycin Accordpharma
- Slovenia · Daptomicin Accord Healthcare, Daptomicin Accordpharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/17eeb5af-bdb1-4dda-8348-380e91a68792 GET /v1/drugs/17eeb5af-bdb1-4dda-8348-380e91a68792?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania roztworu do wstrzykiwań lub infuzji",
"source": "urpl",
"strength": "350 mg",
"packaging": "05909990627271 ¦ Rp ¦ EU/1/05/328/001 ¦ 34313\n1 fiol. 10 ml\nRp ¦ EU/1/05/328/003 ¦ 103680\n5 fiol. 10 ml",
"substance": "Daptomycinum 350 mg",
"common_name": "Daptomycinum",
"pl_product_id": "100165318",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about daptomycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.